Quick diagnosis of ventilator pneumonia in critically ill children
Part of Infections, Lungs & breathing clinical trials.
This study tests a new way to quickly diagnose pneumonia in children on breathing machines in the ICU. It uses information from the body and germs to find the right treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be in the pediatric intensive care unit (PICU).
- Your child must have been on a breathing machine (ventilator) for at least 48 hours.
- Your child cannot be expected to pass away soon or be on a comfort-only care plan.
- Your child cannot have a tracheostomy (breathing tube through the neck) already in place.
- Your child cannot have a weakened immune system or be on medicines that weaken the immune system.
- Your child cannot have had a full course of antibiotics in the past 6 weeks.
- Your child cannot have known or suspected tuberculosis (TB).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a fast respiratory test combined with a treatment plan can help doctors choose the right antibiotics sooner for patients in the intensive care unit who get pneumonia from a breathing machine. It aims to improve treatment and reduce unnecessary antibiotics.
This trial compares starting antibiotics right away versus waiting for more test results in people on a breathing machine who may have pneumonia. The goal is to find out which approach works better without causing harm.
This study tests if a protein in your blood (heparin-binding protein) can help doctors diagnose ventilator-associated pneumonia (VAP) earlier and predict how it will progress. It may be an option if you are on a breathing machine and have signs of pneumonia.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This study looks at different types of lung infections in ICU patients on breathing machines. By analyzing fluid from your lungs, researchers hope to better understand pneumonia and improve treatment.
This trial uses a rapid test (PCR) to check for bacteria in your lung fluid, so doctors can pick the right antibiotics faster. It's for ICU patients on a breathing machine who may have a lung infection.
Hear when a new Ventilator Associated Pneumonia ( VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.